Blacksmith Medicines Announces Upcoming Presentation at AACR Annual Meeting 2024
SAN DIEGO, California, March 6, 2024 – Blacksmith Medicines, [...]
Blacksmith Medicines Announces $3.3M in Funding from NIAID to Support Clinical Trial Manufacturing of Novel Antibiotic
SAN DIEGO, California, February 21, 2024 – Blacksmith Medicines, [...]
Blacksmith Medicines and Zoetis Announce Research Collaboration for Novel Animal Health Antibiotics
SAN DIEGO, California, February 14, 2024 – Blacksmith Medicines, [...]
Blacksmith Medicines announces oncology scientific advisors
SAN DIEGO, California, January 5, 2023 – Blacksmith Medicines, [...]
Blacksmith Medicines announces merger with Forge Therapeutics to create leading company developing medicines targeting metalloenzymes
SAN DIEGO, California, January 2, 2023 – Blacksmith Medicines, [...]
Blacksmith Medicines launches with seed funding and a research collaboration with Lilly
-Blacksmith Medicines, a spin-out of Forge Therapeutics, is pioneering [...]